DSpace@nitr >
National Institue of Technology- Rourkela >
Conference Papers >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2080/860

Full metadata record

DC FieldValueLanguage
contributor.authorPaul, S-
date.accessioned2009-05-20T02:27:36Z-
date.available2009-05-20T02:27:36Z-
date.issued2008-
identifier.citationWiley, BioEssays, Voulme 30, Issue 11-12, 2008, Pages 1172-1184en
identifier.urihttp://dx.doi.org/10.1002/bies.20852-
identifier.urihttp://hdl.handle.net/2080/860-
description.abstractThe ubiquitin-proteasome system (UPS) is the major proteolytic pathway that degrades intracellular proteins in a regulated manner. Deregulation of the UPS has been implicated in the pathogenesis of many neurodegenerative disorders like Alzheimer's disease, Parkinson's diseases, Huntington disease, Prion-like lethal disorders, in the pathogenesis of several genetic diseases including cystic fibrosis, Angelman's syndrome and Liddle syndrome and in many cancers. Multiple lines of evidence have already proved that UPS has the potential to be an exciting novel therapeutic target for the treatment of these diseases. Here I review how aberrant functions of various genes have implicated UPS in many human disorders including neurodegeneration and cancers. I also discuss the finding that some proteasome inhibitors possess a therapeutic potential as drugs against many such diseases.en
format.extent9457483 bytes-
format.mimetypeapplication/pdf-
language.isoen-
publisherWileyen
titleDysfunction of the Ubiquitin-Proteasome System in Multiple Disease Conditions: Therapeutic Approachesen
typeArticleen
Appears in Collections:Conference Papers

Files in This Item:

File Description SizeFormat
BioEssays.pdf9235KbAdobe PDFView/Open

Show simple item record

All items in DSpace are protected by copyright, with all rights reserved.

 

Powered by DSpace Feedback